GENE ONLINE|News &
Opinion
Blog

Antibody
Antibody
ExeVir Bio’s COVID-19 Neutralizing Antibody Derived From Llamas Advances to Phase 1 Trials
2021-08-19
COVID-19 Antibody Therapy
Korea’s Celltrion Pushes for Broader Use of COVID-19 Treatment both Domestically And Abroad
2021-08-12
M&A Antibody Therapy
Amgen Acquires Teneobio to Snag New Class of Antibody Therapies
2021-07-31
Trials & Approvals Alzheimer's Drug
Aftermath of Biogen’s Alzheimer’s Drug Approval Continues as Some Hospitals, Insurers Refuse Administration
2021-07-18
Trials & Approvals
FDA Rejection of Type 1 Diabetes Drug Impacts Provention Bio’s Stocks
2021-07-07
Alzheimer's Drug
China’s Simcere Gains Regional Rights for Two Alzheimer’s Drugs
2021-07-01
COVID-19 Antibody
FDA Grants Emergency Use Authorization to Third COVID-19 Antibody Therapy
2021-05-27
R&D USAG-1
A Novel Antibody Therapy to Rescue Congenital Teeth Defects
2021-04-04
COVID-19 COVID-19 Variant
Vir, GSK’s Antibody Therapy Effective Against COVID-19 Variants, Reduces Hospitalization and Deaths by 85%
2021-03-11
Startups Antibody
With $74 Million in Fresh Capital, Belgian Startup Aims to Advance its Regenerative Pathway Modulators
2021-03-11
Trials & Approvals Oncology
BITT’s TNFR2 Antagonist to Enter Clinical Trials In Collaboration with BeiGene
2021-02-20
COVID-19 COVID-19 Variant
Lilly Teams up with GSK, Vir to Fight New COVID-19 Variants Using Antibody Combo
2021-01-28
Trials & Approvals
Vir Biotech’s Investigational Antibody Therapy Shows Promise in 8-Patient Phase 1 HBV Trial
2021-01-27
COVID-19
Regeneron Looks to Achieve “Passive Vaccination” with COVID-19 Antibody Cocktail
2021-01-27
COVID-19 Antibody
Lilly’s Antibody Treatment Prevents COVID-19 Spread at Nursing Home
2021-01-23
1 2 3 4 5 6
LATEST
The Gene & Cell Therapy Landscape: Recent Approvals and Upcoming Therapeutics of Interest
2024-05-06
Exploring Key Areas of RNA Therapeutics Development: Your Blueprint for Maximizing ASGCT Content
2024-05-06
Mastering Gene & Cell Therapy: Your Blueprint for Maximizing ASGCT Content
2024-05-06
Pfizer’s Q1 2024 Revenue Declines, Offset by Strong Performance of Non-COVID-19 Products
2024-05-03
Novo Nordisk Revises Outlook: Reports 24% Growth in Q1 2024 Sales, Reaching DKK 65.3 Billion
2024-05-03
UC Riverside Scientists Unveil RNA-based Vaccine Strategy, Potentially Avoiding Endless Booster Shots
2024-05-02
Lilly’s Q1 2024 Financial Report: Full-Year Revenue Outlook Raised by $2 Billion, with a 67% Net Income Increase
2024-05-02
READ MORE
EVENT
SEE MORE
Newsletter

Subscribe to receive updates.

SIGN UP
Facebook
Youtube
Twitter
Linkedin
About
Explore
More
© 2024 GeneOnline
Privacy Policy | Terms of Service
Privacy Policy | Terms of Service
  • Subscribe to our newsletter and dive into the world of biopharma with us.
SIGN UP
x
Scroll to Top